NCT05912556 (BRIGHT-Mind) is a NA clinical trial of Digital Program 1 in Cognition, sponsored by Lumos Labs, Inc..

Who is sponsoring NCT05912556?

NCT05912556 is sponsored by Lumos Labs, Inc..

What drugs are being tested in NCT05912556?

Interventions in NCT05912556: Digital Program 1, Digital Program 2.

What condition does NCT05912556 study?

NCT05912556 studies Cognition, Brain Health, Brain Structure, Brain Function.

Is NCT05912556 still recruiting?

NCT05912556 is currently active, enrolled. Last updated 31 January 2025.

Last reviewed 2025-01-31 · How we verify

NCT05912556: BRIGHT-Mind

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

Active, enrolled NA Last updated 31 January 2025

What this trial tests

NA trial testing Digital Program 1 in Cognition in 816 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

5 July 2023

Primary endpoint
14 March 2025

15 May 2025

Quick facts

Lead sponsor	Lumos Labs, Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	816
Start date	5 July 2023
Primary completion	14 March 2025
Estimated completion	15 May 2025
Sites	1 location across United States

Drugs / interventions tested

Digital Program 1
Digital Program 2

Conditions studied

Cognition — all drugs for Cognition →
Brain Health — all drugs for Brain Health →
Brain Structure — all drugs for Brain Structure →
Brain Function — all drugs for Brain Function →

Sponsor

Lumos Labs, Inc.

Who can join

Adults 25 to 80, any sex, with Cognition or Brain Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cognition

Currently open trials in the same condition.

NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
NCT07109505 — Nutrition to Support Postoperative Recovery · NA · recruiting
NCT07334392 — Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairm · NA · recruiting
NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
NCT07231497 — Cognitive Strategies in Early Psychosis 1 · Phase 3 · recruiting

Other Lumos Labs, Inc. trials

Trials by the same sponsor.

NCT06376175 — Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program · completed
NCT05296473 — Guided ADHD Therapy for Managing the Extent and Severity of Symptoms · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05912556 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lumos Labs, Inc.
Last refreshed: 31 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05912556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing